Business:
Immunes system mapping with AI
About:
Immunai is developing AI-powered solutions to revolutionize the discovery and development of immunotherapies. The company's platform integrates single-cell multiomics, machine learning, and big data computing to map the immune system at scale. Immunai's insights are used to identify and validate novel therapeutic targets and to develop new immunotherapies that are more effective and less toxic than existing treatments. Immunai's pipeline includes programs in a variety of therapeutic areas, including cancer, infectious diseases, and autoimmune diseases. The company's lead product candidate, IMI-101, is a small molecule inhibitor of a key checkpoint molecule that is involved in the suppression of the immune system. IMI-101 is currently in Phase 1 clinical trials for the treatment of advanced solid tumors.
Senior Scientist - Functional Genomics New York, NY|8 days ago
Office Manager New York, NY|8 days ago
Senior Scientist, Functional Genomics New York, NY|8 days ago
Team Lead - LLM Agents for Biological Reasoning Ramat Gan, Tel Aviv District, Israel|9 days ago
Machine Learning Engineer Ramat Gan, Tel Aviv District, Israel|23 days ago
**** ******** ***** ***, *** **** ********, ******|39 days ago
****** ************* ********* *** ****, **|44 days ago
Director of Product - Target Discovery New York, NY|99 days ago
**** ******** ******, ******, *******|100+ days ago
Senior Computational Biologist, External Collabora... New York, NY|100+ days ago
(Senior) Director of Preclinical Programs New York, NY|Not provided